PAR 2.17% 23.5¢ paradigm biopharmaceuticals limited..

Where we at?, page-62

  1. 4,296 Posts.
    lightbulb Created with Sketch. 6816
    Mate, I'm on this soap box and I cant get off....I promise I will, I have a few things on the Mozz agenda list to get done before the day is done...

    https://hotcopper.com.au/data/attachments/6084/6084336-fbd66b3b1cc3e7658adf52b01414e8c4.jpg

    I met a daughter of a colleague today to talk a little investing 101's. She's a vet final year student.

    Did we talk about PPS?


    Is the Earth round?


    Mate, she knew about Catrophen, she didn't know the active ingredient. But before I mentioned it I wanted to hear her observations.

    She said Catrophen was an amazing product and has an immaculate safety profile that vets have been using for years.


    She (without any Mozz prompts) talked about Dogs having allergies too...I said

    "What? You mean like hay Fever !?".

    She said "No no but they get rashes that are allergy based".

    I asked her why she brought that up...she said that she had seen owners of dogs that had taken Cartrophen for the dog's arthritis and these rashes had simultaneously vanished.





    Mate...I also have heard of a couple of human examples where the Hay Fever in the season that the patient took iPPS also disappeared!



    One day we will have a P3 in Hay Fever, an additional broadening of that all important label. Maybe they might even market it separately. We prob won't care at that stage, we'll -hopefully- be too engrossed in OA and Pain relief sales and massive YOY growth?


    sneaky.png
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.5¢
Change
0.005(2.17%)
Mkt cap ! $82.20M
Open High Low Value Volume
23.5¢ 23.5¢ 23.0¢ $85.35K 365.1K

Buyers (Bids)

No. Vol. Price($)
10 280011 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 44703 3
View Market Depth
Last trade - 16.10pm 06/09/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.